Cargando…
Quality improvement project designed to reduce disproportionate growth in extremely low gestational age neonates: cognitive neurodevelopmental outcome at 18–41 months
OBJECTIVE: To assess if the adjusted odds of low composite cognitive Bayley-III scores changed after implementing a single-institution quality improvement (QI) project designed to decrease discharge Z-scores for weight, body mass index (BMI), and weight-for-length, but not length or fronto-occipital...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995674/ https://www.ncbi.nlm.nih.gov/pubmed/33772110 http://dx.doi.org/10.1038/s41372-021-01047-0 |
_version_ | 1783669959173341184 |
---|---|
author | Reis, Jordan D. Tolentino-Plata, Kristine Heyne, Roy Brown, L. Steven Rosenfeld, Charles R. Caraig, Maria Burchfield, Patti J. Brion, Luc P. |
author_facet | Reis, Jordan D. Tolentino-Plata, Kristine Heyne, Roy Brown, L. Steven Rosenfeld, Charles R. Caraig, Maria Burchfield, Patti J. Brion, Luc P. |
author_sort | Reis, Jordan D. |
collection | PubMed |
description | OBJECTIVE: To assess if the adjusted odds of low composite cognitive Bayley-III scores changed after implementing a single-institution quality improvement (QI) project designed to decrease discharge Z-scores for weight, body mass index (BMI), and weight-for-length, but not length or fronto-occipital circumference (FOC) in infants 23–28 weeks gestational age (GA). METHODS: Compare Bayley-III outcomes at ≥18 months corrected age (postnatal age adjusted for prematurity) in infants tested before (Epoch-1) and after (Epoch-2) QI implementation. RESULTS: Bayley testing was available in 134/156 infants (86%) in Epoch-1 and 139/175 (79%) in Epoch-2. There was no change in frequency of low (<85) cognitive score (p = 0.5) or in median cognitive scores (80 in Epoch-1 vs. 85 Epoch-2, p = 0.35). The adjusted odds of low cognitive scores was not different between Epochs. CONCLUSION: No change in cognitive outcome at ≥18 months corrected age was observed after implementing a QI project designed to reduce discharge weight-for-length disproportion in very preterm infants. |
format | Online Article Text |
id | pubmed-7995674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-79956742021-03-26 Quality improvement project designed to reduce disproportionate growth in extremely low gestational age neonates: cognitive neurodevelopmental outcome at 18–41 months Reis, Jordan D. Tolentino-Plata, Kristine Heyne, Roy Brown, L. Steven Rosenfeld, Charles R. Caraig, Maria Burchfield, Patti J. Brion, Luc P. J Perinatol Article OBJECTIVE: To assess if the adjusted odds of low composite cognitive Bayley-III scores changed after implementing a single-institution quality improvement (QI) project designed to decrease discharge Z-scores for weight, body mass index (BMI), and weight-for-length, but not length or fronto-occipital circumference (FOC) in infants 23–28 weeks gestational age (GA). METHODS: Compare Bayley-III outcomes at ≥18 months corrected age (postnatal age adjusted for prematurity) in infants tested before (Epoch-1) and after (Epoch-2) QI implementation. RESULTS: Bayley testing was available in 134/156 infants (86%) in Epoch-1 and 139/175 (79%) in Epoch-2. There was no change in frequency of low (<85) cognitive score (p = 0.5) or in median cognitive scores (80 in Epoch-1 vs. 85 Epoch-2, p = 0.35). The adjusted odds of low cognitive scores was not different between Epochs. CONCLUSION: No change in cognitive outcome at ≥18 months corrected age was observed after implementing a QI project designed to reduce discharge weight-for-length disproportion in very preterm infants. Nature Publishing Group US 2021-03-26 2021 /pmc/articles/PMC7995674/ /pubmed/33772110 http://dx.doi.org/10.1038/s41372-021-01047-0 Text en © The Author(s), under exclusive licence to Springer Nature America, Inc. 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Reis, Jordan D. Tolentino-Plata, Kristine Heyne, Roy Brown, L. Steven Rosenfeld, Charles R. Caraig, Maria Burchfield, Patti J. Brion, Luc P. Quality improvement project designed to reduce disproportionate growth in extremely low gestational age neonates: cognitive neurodevelopmental outcome at 18–41 months |
title | Quality improvement project designed to reduce disproportionate growth in extremely low gestational age neonates: cognitive neurodevelopmental outcome at 18–41 months |
title_full | Quality improvement project designed to reduce disproportionate growth in extremely low gestational age neonates: cognitive neurodevelopmental outcome at 18–41 months |
title_fullStr | Quality improvement project designed to reduce disproportionate growth in extremely low gestational age neonates: cognitive neurodevelopmental outcome at 18–41 months |
title_full_unstemmed | Quality improvement project designed to reduce disproportionate growth in extremely low gestational age neonates: cognitive neurodevelopmental outcome at 18–41 months |
title_short | Quality improvement project designed to reduce disproportionate growth in extremely low gestational age neonates: cognitive neurodevelopmental outcome at 18–41 months |
title_sort | quality improvement project designed to reduce disproportionate growth in extremely low gestational age neonates: cognitive neurodevelopmental outcome at 18–41 months |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995674/ https://www.ncbi.nlm.nih.gov/pubmed/33772110 http://dx.doi.org/10.1038/s41372-021-01047-0 |
work_keys_str_mv | AT reisjordand qualityimprovementprojectdesignedtoreducedisproportionategrowthinextremelylowgestationalageneonatescognitiveneurodevelopmentaloutcomeat1841months AT tolentinoplatakristine qualityimprovementprojectdesignedtoreducedisproportionategrowthinextremelylowgestationalageneonatescognitiveneurodevelopmentaloutcomeat1841months AT heyneroy qualityimprovementprojectdesignedtoreducedisproportionategrowthinextremelylowgestationalageneonatescognitiveneurodevelopmentaloutcomeat1841months AT brownlsteven qualityimprovementprojectdesignedtoreducedisproportionategrowthinextremelylowgestationalageneonatescognitiveneurodevelopmentaloutcomeat1841months AT rosenfeldcharlesr qualityimprovementprojectdesignedtoreducedisproportionategrowthinextremelylowgestationalageneonatescognitiveneurodevelopmentaloutcomeat1841months AT caraigmaria qualityimprovementprojectdesignedtoreducedisproportionategrowthinextremelylowgestationalageneonatescognitiveneurodevelopmentaloutcomeat1841months AT burchfieldpattij qualityimprovementprojectdesignedtoreducedisproportionategrowthinextremelylowgestationalageneonatescognitiveneurodevelopmentaloutcomeat1841months AT brionlucp qualityimprovementprojectdesignedtoreducedisproportionategrowthinextremelylowgestationalageneonatescognitiveneurodevelopmentaloutcomeat1841months |